Ledger.Open graph →
SEC Form D · Amendment · filed June 26, 2017

Amphivena Therapeutics, Inc

Offering
$19.5M
Sold
$19.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jeanmarie Guenot · San Francisco, CAExec · DirectorLuke Evnin · Boston, MADirectorFlorian Fischer · San Francisco, CADirectorHaroon W. Inam · Union City, CADirectorRobert L. Skinner · Santa Barbara, CADirectorJose M. De La Infiesta · BARCELONA, U3Exec · DirectorWilliam B. Nitze · Los Angeles, CAExec · DirectorDevesh Gandhi · BOSTON, MADirectorMichael A. Brumagin · Richmond, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗